A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2004
12/01/2004	EP1183040B1 Therapeutic use of an inhibitor of a hedgehog signalling pathway
12/01/2004	EP1176975A4 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration
12/01/2004	EP1119538B1 Derivatives of phenantrene for medicinal use and a process for their preparation
12/01/2004	EP1059943B1 Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles
12/01/2004	EP0977745B1 Thioaryl sulfonamide hydroxamic acid compounds
12/01/2004	CN1551919A 治疗性结合分子 Therapeutic binding molecules
12/01/2004	CN1551878A 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/01/2004	CN1551769A Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
12/01/2004	CN1551760A Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177832C Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion
12/01/2004	CN1177831C New benzimidazolone-benzoxazolone-, or benzothiazoloe derivatives as ion channel modulating agents
12/01/2004	CN1177828C Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
12/01/2004	CN1177824C Hydroxy formamidine derivs. and medicines contg. same
12/01/2004	CN1177805C Method for reducnig 2-dimethylamio-2-phenylpropion-acid ethyl ester content in solutions of 2-dimethylamino-1-phenyl-3-cyclohexene-1- carboxylic acid ethy ester
11/2004
11/30/2004	US6826033 Beta 3 adrenergic receptor agonists; treatment of pollakiuria, urinary incontinence, obesity or diabetes
11/30/2004	US6825355 For therapy of immunologic disorders such as transplant rejection, rheumatoid arthritis. multiple sclerosis, inflammatory bowel disease, lupus, graft vs. host disease
11/30/2004	US6825231 Substituted norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and a medicament comprising them
11/30/2004	US6825207 Anticancer agents
11/30/2004	US6825200 Substituted dipeptides having nos inhibiting activity
11/30/2004	US6825198 5-HT receptor ligands and uses thereof
11/30/2004	US6825197 Cyclic GMP-specific phosphodiesterase inhibitors
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/30/2004	US6825184 For use as anti-inflammatory agents
11/30/2004	CA2362117C A system for cell-based screening
11/30/2004	CA2298245C Matrix controlled release device
11/30/2004	CA2089309C Novel pharmaceutical uses of bilobalide and derivatives thereof and pharmaceutical compositions adapted for such use
11/25/2004	WO2004101775A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	WO2004101593A1 5'-modified nucleoside derivative and medicinal use thereof
11/25/2004	WO2004101529A1 Nitrogenous heterocyclic compound and medical use thereof
11/25/2004	WO2004101514A1 Cyanofluoropyrrolidine derivative
11/25/2004	WO2004100976A1 Klotho protein, anti-klotho protein antibody and use thereof
11/25/2004	WO2004100972A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	WO2004100944A1 Bicalutamide forms, compositions, and processes thereof
11/25/2004	WO2004067002A3 SELECTIVE mGlu5 ANTAGONISTS FOR TREATMENT OF NEUROMUSCULAR DYSFUNCTION OF THE LOWER URINARY TRACT
11/25/2004	WO2003070197A3 RNA INTERFERENCE MEDIATED INHIBITION OF TGF-BETA AND TGF-BETA RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/25/2004	US20040236104 Substituted 4-aminocyclohexanols
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040236100 For therapy of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
11/25/2004	US20040236073 A polypeptide with at least one amino acid replacement at position at 132, 134, 170, or 181; agonist of MET receptor
11/25/2004	US20040235933 Administering aromatic or heteroaromatic substituted indolealkanoic acid derivataives for the treatment of chronic complications arising from diabetes mellitus e.g. diabetic cataracts, retinopathy, nephropathy and neuropathy
11/25/2004	US20040235930 Indole derivatives and their use for the treatment of osteoporosis amongst other applications
11/25/2004	US20040235919 Useful in treating cell proliferative disorders associated with an altered cell cycle dependent kinase activity; cancer, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders
11/25/2004	US20040235894 N-[[4-(2-Chloro-4-fluorophenoxy)[1,4'-bipiperidin]-1'-yl]carbonyl]-4-methyl benzenesulfonamide, used for prophylaxis of asthma and/or rhinitis; respiratory system disorders
11/25/2004	US20040235887 Carbamates derived from arylalkylamines
11/25/2004	US20040235863 As stimulators for soluble guanylate cyclase and to their use as agents in the therapy of cardiovascular diseases, hypertonicity, thrombo-embolic diseases and ischemia, sexual dysfunction or inflammations and for the treatment of diseases of the central nervous system
11/25/2004	US20040235859 Novel piperazine derivatives
11/25/2004	US20040235838 Use of 2-alkoxyphenol-substituted imidazotriazinones
11/25/2004	US20040235837 Method for treating fibrotic diseases or other indications IE
11/25/2004	US20040235830 Substituted cyclohexane derivatives and the use thereof in medicaments for treating cardiovascular diseases
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/25/2004	US20040235818 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/25/2004	US20040235095 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer
11/25/2004	US20040234632 Use of oil from seeds of gourd family members chosen from Lagenaria, Luffa, and Momordica for preparing composition to inhibit 5a-reductase activity; for treatment of prostatic hypertrophy, prostatic adenoma, acne, hyperseborrhea, alopecia and hirsutism
11/25/2004	CA2526025A1 Preventive and/or remedy for diseases accompanied by tissue destruction
11/25/2004	CA2525909A1 Novel stem cell derived from adult tissue and use thereof
11/25/2004	CA2525442A1 Cyanofluoropyrrolidine derivatives
11/25/2004	CA2525318A1 Bicalutamide forms, compositions, and processes thereof
11/24/2004	EP1479768A1 Novel screening method
11/24/2004	EP1479684A1 Thienopyrimidines, process for preparing the same and use thereof
11/24/2004	EP1479670A1 Novel fused ring indazole compounds
11/24/2004	EP1479393A1 Stabilized albumin preparations
11/24/2004	EP1479384A1 Fibrosis inhibitor
11/24/2004	EP1479300A1 Amino acid powder and process for producing the same
11/24/2004	EP1478762A2 Nucleic acid-associated proteins
11/24/2004	EP1478659A2 Biologically active peptides
11/24/2004	EP1478645A2 Quinolinone derivatives for treating cell proliferation related disorders
11/24/2004	EP1478639A1 Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
11/24/2004	EP1478627A1 Method
11/24/2004	EP1478624A1 Chemical compounds
11/24/2004	EP1478613A2 Substituted 10-aryl-11h-benzo[b]fluorenes and 7-aryl-5,6-dihydro-benz[a]anthracenes for selective effects on estrogen receptors
11/24/2004	EP1478378A2 Anti-allergic complex molecules
11/24/2004	EP1478361A2 Arylsulfone derivatives
11/24/2004	EP1478357A2 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents
11/24/2004	EP1478354A2 Use of tgf-beta antagonists to treat or to prevent chronic transplant rejection
11/24/2004	EP1313496B1 Use of a composition comprising an extract of pollen for the treatment of edema
11/24/2004	EP1313495B1 Use of a composition comprising an extract of pollen for the treatment of hormonally-related disorders
11/24/2004	EP1313493B1 Use of a composition comprising an extract of pollen for the treatment of irritability
11/24/2004	EP1313492B1 Use of a composition comprising an extract of pollen for the treatment of dysphoria
11/24/2004	EP1272201B1 Use of compatible solutes as substances having free radical scavenging properties
11/24/2004	EP1267841B1 Controlled release pharmaceutical composition containing midodrine and/or desglymidodrine
11/24/2004	EP1200406B1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor
11/24/2004	EP1175214B1 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
11/24/2004	EP1159265B1 C-16 unsaturated fp-selective prostaglandins analogs
11/24/2004	EP1094711B1 Methods for eradication of nanobacteria
11/24/2004	EP1003496B1 Medicament for treating prostate intraepithelial neoplasia
11/24/2004	CN1549822A Methylene-4-azasteroids
11/24/2004	CN1549816A N-aroyl cyclic amine derivatives as orexin receptor antagonists
11/24/2004	CN1549814A Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
11/24/2004	CN1549812A Pyrazole compounds useful as protein kinase inhibitors.
11/24/2004	CN1549803A 维生素d的类似物 Analogs of vitamin d
11/24/2004	CN1549714A Aminoisoxazole derivatives active as kinase inhibitors
11/24/2004	CN1549705A Extended release oral dosage form
11/24/2004	CN1548446A Isopamicin and its salt and their prepn
11/24/2004	CN1548436A Novel 2-alkyl substituted imidazole compounds
11/24/2004	CN1548145A Medicine composition containing epimedium extract
11/24/2004	CN1548110A Calculus-expelling Jinshi bolus and its prepn
11/24/2004	CN1548095A Kidney-warming prostatosis treating bolus and its prepn
11/24/2004	CN1176941C Caspase inhibitors and the use thereof
11/24/2004	CN1176922C 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors

1 ... 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 ... 562